Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Wui-Jin Koh(Yale Cancer Center), Nadeem R. Abu‐Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David E. Cohn, Marta A. Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel(Yale Cancer Center), Christine M. Fisher(Yale Cancer Center), Peter J. Frederick, David K. Gaffney(Yale Cancer Center), Suzanne George, Ernest Han, Susan A. Higgins, Warner K. Huh, John R. Lurain, Andrea Mariani, David G. Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda N. Fader, Steven W. Remmenga, R. Kevin Reynolds, T. Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar(Yale Cancer Center), Nicole R. McMillian, Jillian L. Scavone
Cited by 657Open Access
Abstract
Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy. Approximately two-thirds of endometrial carcinoma cases are diagnosed with disease confined to the uterus. The complete NCCN Guidelines for Uterine Neoplasms provide recommendations for the diagnosis, evaluation, and treatment of endometrial cancer and uterine sarcoma. This manuscript discusses guiding principles for the diagnosis, staging, and treatment of early-stage endometrial carcinoma as well as evidence for these recommendations.
Related Papers
No related papers found
Powered by citation graph analysis